Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host

References

• Yeung KHT, Duclos P, Nelson EAS, et al. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017;17(9):974–980.
   PubMed Web of Science ®Google Scholar
• WHO. https://www.who.int/data/gho/data/themes/immunization.
   Google Scholar
• Guiso N, Wirsing von Knig CH, Forsyth K, et al. The global pertussis initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11–12 January 2010. Vaccine. 2011;29(6):1115–1121.
   PubMedGoogle Scholar
• Hegerle N, Dore G, Guiso N. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. Vaccine. 2014;32(49):6597–6600.
   PubMed Web of Science ®Google Scholar
• Wilkinson K, Righolt CH, Elliott LJ, et al. Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis. Vaccine. 2021;39(23):3120–3130.
   PubMed Web of Science ®Google Scholar
• Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med. 2015;13(1):146.
   PubMedGoogle Scholar
• Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis. 2012;206(6):902–906.
   PubMed Web of Science ®Google Scholar
• Anderson RM, May RM. Directly transmitted infections diseases: control by vaccination. Science. 1982;215(4536):1053–1060.
   PubMed Web of Science ®Google Scholar
• Guerra FM, Bolotin S, Lim G, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017;17(12):e420–e428. e420-e428.
   PubMed Web of Science ®Google Scholar
• Gani R, Leach S. Transmission potential of smallpox in contemporary populations. Nature. 2001;414(6865):748–751.
   PubMed Web of Science ®Google Scholar
• Kretzschmar M, Teunis PFM, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European Countries. PLoS Med. 2010;7(6):e1000291.
   PubMed Web of Science ®Google Scholar
• von Wintzingerode F, Schattke A, Siddiqui RA, et al. Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int J System Evol Microbiol. 2001;51(4):1257–1265.
   PubMedGoogle Scholar
• Wang F, Grundmann S, Schmid M, et al. Isolation and characterization of 1,2,4-trichlorobenzene mineralizing Bordetella sp. and its bioremediation potential in soil. Chemosphere. 2007;67(5):896–902.
   PubMed Web of Science ®Google Scholar
• Bachate SP, Khapare RM, Kodam KM. Oxidation of arsenite by two beta-proteobacteria isolated from soil. Appl Microbiol Biotechnol. 2012;93(5):2135–2145.
   PubMed Web of Science ®Google Scholar
• Hamidou Soumana I, Linz B, Harvill ET. Environmental origin of the genus Bordetella. Front Microbiol. 2017;8:28.
   PubMedGoogle Scholar
• Melvin JA, Scheller EV, Miller JF, et al. Bordetella pertussis pathogenesis: current and future challenges. Nature Rev Microbiol. 2014;12(4):274–288.
   PubMed Web of Science ®Google Scholar
• Hoffman CL, Gronyar LA, Zacca F, et al. Bordetella pertussis can be motile and express flagellum-like structures. mBio. 2019;10(3):e00787–19.
   PubMed Web of Science ®Google Scholar
• Cummings CA, Bootsma HJ, Relman DA, et al. Species- and strain-specific control of a complex, flexible regulon by Bordetella BvgAS. J Bacteriol. 2006;188(5):1775–1785.
   PubMed Web of Science ®Google Scholar
• Taylor-Mulneix DL,Bendor L, Linz B, et al. Bordetella bronchiseptica exploits the complex life cycle of Dictyostelium discoideum as an amplifying transmission vector. PLoS Biol. 2017;15(4):e2000420.
   PubMed Web of Science ®Google Scholar
• Hao X, Lthje F, Ronn R, et al. A role for copper in protozoan grazing – two billion years selecting for bacterial copper resistance. Mol Microbiol. 2016;102(4):628–641.
   PubMed Web of Science ®Google Scholar
• José Maschio V, Corçao G, Rott MB. Identification of Pseudomonas spp. as amoeba-resistant microorganisms in isolates of acanthamoeba. Rev Inst Med Trop São Paulo. 2015;57(1):81–83.
   PubMed Web of Science ®Google Scholar
• Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev. 2004;17(2):413–433.
   PubMed Web of Science ®Google Scholar
• Hägele S, Khler R, Merkert H, et al. Dictyostelium discoideum: a new host model system for intracellular pathogens of the genus Legionella. Cell Microbiol. 2000;2(2):165–171.
   PubMed Web of Science ®Google Scholar
• Cirillo JD, Falkow S, Tompkins L, et al. Interaction of Mycobacterium avium with environmental amoebae enhances virulence. Infect Immun. 1997;65(9):3759–3767.
   PubMed Web of Science ®Google Scholar
• DiSalvo S, Haselkorn TS, Bashir U, et al. Burkholderia bacteria infectiously induce the proto-farming symbiosis of Dictyostelium amoebae and food bacteria. Proc Natl Acad Sci USA. 2015;112(36):E5029–E5037. E5029-E5037.
   PubMed Web of Science ®Google Scholar
• Rivera I, Linz B, Harvill ET. Evolution and conservation of Bordetella intracellular survival in eukaryotic host cells. Front Microbiol. 2020;11:557819.
   PubMed Web of Science ®Google Scholar
• Lamberti Y, Gorgojo J, Massillo C, et al. Bordetella pertussis entry into respiratory epithelial cells and intracellular survival. Pathog Dis. 2013;69(3):194–204.
   PubMed Web of Science ®Google Scholar
• Lamberti Y,Perez Vidakovics ML, van der Pol LW, et al. Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils. Microb Pathog. 2008;44(6):501–511.
   PubMed Web of Science ®Google Scholar
• Lamberti YA, Hayes JA, Perez Vidakovics ML, et al. Intracellular trafficking of Bordetella pertussis in human macrophages. Infect Immun. 2010;78(3):907–913.
   PubMed Web of Science ®Google Scholar
• Englund L, Jacobs AAC, Klingeborn B, et al. Seroepidemiological survey of Bordetella bronchiseptica and canine parainfluenza-2 virus in dogs in Sweden. Vet Rec. 2003;152(9):251–254.
   PubMed Web of Science ®Google Scholar
• Hoskins JD,Williams J, Roy AF, et al. Isolation and characterization of Bordetella bronchiseptica from cats in southern Louisiana. Vet Immunol Immunopathol. 1998;65(2):173–176.
   PubMed Web of Science ®Google Scholar
• By S, Nr U, Te S. Serologic survey for Bordetella bronchiseptica in Nebraska specific-pathogen-free pigs. Am J Vet Res. 1983;44(6):1123–1125.
   PubMed Web of Science ®Google Scholar
• Gupta S, Goyal P, Mattana J. Bordetella bronchiseptica pneumonia a thread in the diagnosis of human immunodeficiency virus infection. IDCases. 2019;15:e00509.
   PubMed Web of Science ®Google Scholar
• He Q, Viljanen MK, Arvilommi H, et al. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA. 1998;280(7):635–637.
   PubMed Web of Science ®Google Scholar
• Bjørnstad ON, Harvill ET. Evolution and emergence of Bordetella in humans. Trends Microbiol. 2005;13(8):355–359.
   PubMed Web of Science ®Google Scholar
• Novembre J, Han E. Human population structure and the adaptive response to pathogen-induced selection pressures. Philos Trans R Soc Lond, B, Biol Sci. 2012;367(1590):878–886.
   PubMed Web of Science ®Google Scholar
• Diavatopoulos DA, Cummings CA, Schouls LM, et al. Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog. 2005;1(4):e45.
   PubMed Web of Science ®Google Scholar
• Hardin G. The competitive exclusion principle. Science. 1960;131(3409):1292–1297.
   PubMed Web of Science ®Google Scholar
• Chen Q, Stibitz S. The BvgASR virulence regulon of Bordetella pertussis. Curr Opin Microbiol. 2019;47:74–81.
   PubMed Web of Science ®Google Scholar
• Coutte L, Antoine R, Slupek S, et al. Combined RNAseq and ChIPseq analyses of the BvgA virulence regulator of Bordetella pertussis. mSystems. 2020;5(3):e00208–20.
   Google Scholar
• Melton AR, Weiss AA. Environmental regulation of expression of virulence determinants in Bordetella pertussis. J Bacteriol. 1989;171(11):6206–6212.
   PubMed Web of Science ®Google Scholar
• Seydlova G, Beranova G, Bibova I, et al. The extent of the temperature-induced membrane remodeling in two closely related Bordetella species reflects their adaptation to diverse environmental niches. J Biol Chem. 2017;292(19):8048–8058.
   PubMed Web of Science ®Google Scholar
• Cotter PA, Miller JF. A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol. 1997;24(4):671–685.
   PubMed Web of Science ®Google Scholar
• Deora R, Bootsma HJ, Miller JF, et al. Diversity in the Bordetella virulence regulon: transcriptional control of a Bvg-intermediate phase gene. Mol Microbiol. 2001;40(3):669–683.
   PubMed Web of Science ®Google Scholar
• Melton AR, Weiss AA. Characterization of environmental regulators of Bordetella pertussis. Infect Immun. 1993;61(3):807–815.
   PubMed Web of Science ®Google Scholar
• Gestal MC, Whitesides LT, Harvill ET. Integrated signaling pathways mediate Bordetella immunomodulation, persistence, and transmission. Trends Microbiol. 2019;27(2):118–130.
   PubMed Web of Science ®Google Scholar
• Tipton KA, Rather PN. An OmpR-EnvZ two-component system ortholog regulates phase variation, osmotic tolerance, motility, and virulence in Acinetobacter baumannii strain AB5075. J Bacteriol. 2017;199(3):e00705–16.
   PubMed Web of Science ®Google Scholar
• Chen Q, Ng V, Warfel JM, et al. Activation of Bvg-repressed genes in Bordetella pertussis by RisA requires cross talk from noncooperonic histidine kinase RisK. J Bacteriol. 2017;199(22):e00475-17.
   Web of Science ®Google Scholar
• Coutte L, Huot L, Antoine R, et al. The multifaceted RisA regulon of Bordetella pertussis. Sci Rep. 2016;6(1):32774.
   PubMedGoogle Scholar
• Kaut CS, Duncan MD, Yei Kim JI, et al. A novel sensor kinase is required for Bordetella bronchiseptica to colonize the lower respiratory tract. Infect Immun. 2011;79(8):3216–3228.
   PubMed Web of Science ®Google Scholar
• Bone MA, Wilk AJ, Perault AI, et al. Bordetella PlrSR regulatory system controls BvgAS activity and virulence in the lower respiratory tract. Proc Natl Acad Sci USA. 2017;114(8):E1519–E1527. E1519-E1527.
   PubMed Web of Science ®Google Scholar
• Ahuja U, Shokeen B, Cheng N, et al. Differential regulation of type III secretion and virulence genes in Bordetella pertussis and Bordetella bronchiseptica by a secreted anti-σ factor. Proc Natl Acad Sci USA. 2016;113(9):2341–2348.
   PubMed Web of Science ®Google Scholar
• Hanawa T, Kamachi K, Yonezawa H, et al. Glutamate limitation, BvgAS activation, and (p)ppGpp regulate the expression of the Bordetella pertussis type 3 secretion system. J Bacteriol. 2016;198(2):343–351.
   PubMed Web of Science ®Google Scholar
• Goto M, HanawaT, Abe A, et al. transcriptional downregulation of a type III secretion system under reducing conditions in Bordetella pertussis. J Bacteriol. 2020;202(21):e00400–20.
   PubMed Web of Science ®Google Scholar
• Barbier M, Boehm DT, Sen-Kilic E, et al. Modulation of pertussis and adenylate cyclase toxins by sigma factor RpoE in Bordetella pertussis. Infect Immun. 2017;85(1):e00565–16.
   PubMed Web of Science ®Google Scholar
• Clantin B, Hodak H, Willery C, et al. The crystal structure of filamentous hemagglutinin secretion domain and its implications for the two-partner secretion pathway. Proc Natl Acad Sci USA. 2004;101(16):6194–6199.
   PubMed Web of Science ®Google Scholar
• Emsley P, Charles IG, Fairweather NF, et al. Structure of Bordetella pertussis virulence factor P.69 pertactin. Nature. 1996;381(6577):90–92.
   PubMed Web of Science ®Google Scholar
• Heck DV, Trus BL, Steven AC. Three-dimensional structure of Bordetella pertussis fimbriae. J Struct Biol. 1996;116(2):264–269.
   PubMed Web of Science ®Google Scholar
• Scheller EV, Cotter PA. Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential. Pathog Dis. 2015;73(8):ftv079.
   PubMed Web of Science ®Google Scholar
• Chang C-I, Chelliah Y, Borek D, et al. Structure of tracheal cytotoxin in complex with a heterodimeric pattern-recognition receptor. Science. 2006;311(5768):1761–1764.
   PubMed Web of Science ®Google Scholar
• Kitadokoro K, Kamitani S, Miyazawa M, et al. Crystal structures reveal a thiol protease-like catalytic triad in the C-terminal region of Pasteurella multocida toxin. Proc Natl Acad Sci USA. 2007;104(12):5139–5144.
   PubMed Web of Science ®Google Scholar
• Cowell JL, Hewlett EL, Manclark CR. Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun. 1979;25(3):896–901.
   PubMed Web of Science ®Google Scholar
• Fukui A, Horiguchi Y. Bordetella dermonecrotic toxin exerting toxicity through activation of the small GTPase Rho. J Biochem. 2004;136(4):415–419.
   PubMed Web of Science ®Google Scholar
• Kamanova J. Bordetella type III secretion injectosome and effector proteins. Front Cell Infect Microbiol. 2020;10:466.
   PubMed Web of Science ®Google Scholar
• Yahalom A, Davidov G, Kolusheva S, et al. Structure and membrane-targeting of a Bordetella pertussis effector N-terminal domain. Biochim Biophys Acta Biomembr. 2019;1861(12):183054.
   PubMed Web of Science ®Google Scholar
• Tuomanen E, Weiss A. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis. 1985;152(1):118–125.
   PubMed Web of Science ®Google Scholar
• Guerin J, Bigot S, Schneider R, et al. Two-partner secretion: combining efficiency and simplicity in the secretion of large proteins for bacteria-host and bacteria-bacteria interactions. Front Cell Infect Microbiol. 2017;7:148.
   PubMed Web of Science ®Google Scholar
• Tuomanen E, Towbin H, Rosenfelder G, et al. Receptor analogs and monoclonal antibodies that inhibit adherence of Bordetella pertussis to human ciliated respiratory epithelial cells. J Exp Med. 1988;168(1):267–277.
   PubMed Web of Science ®Google Scholar
• Menozzi FD, Boucher PE, Riveau G, et al. Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis. Infect Immun. 1994;62(10):4261–4269.
   PubMed Web of Science ®Google Scholar
• Ashworth LA, Robinson A, Funnell S, et al. Agglutinogens and fimbriae of Bordetella pertussis. Tokai J Exp Clin Med. 1988;13(Suppl: p):203–210.
   PubMedGoogle Scholar
• Edwards JA, Groathouse NA, Boitano S. Bordetella bronchiseptica adherence to cilia is mediated by multiple adhesin factors and blocked by surfactant protein A. Infect Immun. 2005;73(6):3618–3626.
   PubMed Web of Science ®Google Scholar
• Leo JC, Grin I, Linke D. Type V secretion: mechanism(s) of autotransport through the bacterial outer membrane. Philos Trans R Soc Lond, B, Biol Sci. 2012;367(1592):1088–1101.
   PubMed Web of Science ®Google Scholar
• Everest P, Li J, Douce G, et al. Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells. Microbiol-SGM. 1996;142(Pt 11):3261–3268.
   PubMedGoogle Scholar
• Khelef N, Bachelet CM, Vargaftig BB, et al. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect Immun. 1994;62(7):2893–2900.
   PubMed Web of Science ®Google Scholar
• Finn TM, Stevens LA. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol Microbiol. 1995;16(4):625–634.
   PubMed Web of Science ®Google Scholar
• Fernandez RC, Weiss AA. Cloning and sequencing of a Bordetella pertussis serum resistance locus. Infect Immun. 1994;62(11):4727–4738.
   PubMed Web of Science ®Google Scholar
• Marr N, Shah NR, Lee R, et al. Bordetella pertussis autotransporter Vag8 binds human C1 esterase inhibitor and confers serum resistance. PLoS ONE. 2011;6(6):e20585.
   PubMed Web of Science ®Google Scholar
• Stein PE, Boodhoo A, Armstrong, GD, et al. The crystal structure of pertussis toxin. Structure. 1994;2(1):45–57.
   PubMed Web of Science ®Google Scholar
• Weiss AA, Johnson FD, Burns DL. Molecular characterization of an operon required for pertussis toxin secretion. Proc Natl Acad Sci USA. 1993;90(7):1569–1577.
   Web of Science ®Google Scholar
• Locht C, Coutte L, Mielcarek N. The ins and outs of pertussis toxin. FEBS J. 2011;278(23):4668–4682.
   PubMed Web of Science ®Google Scholar
• Kikuchi A, Kozawa Q, Kaibuchi T, et al. Direct evidence for involvement of a guanine nucleotide-binding protein in chemotactic peptide-stimulated formation of inositol bisphosphate and trisphosphate in differentiated human leukemic (HL-60) cells. reconstitution with Gi or Go of the plasma membranes ADP-ribosylated by pertussis toxin. J Biol Chem. 1986;261(25):11558–11562.
   PubMed Web of Science ®Google Scholar
• Katada T, Ui M. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Natl Acad Sci USA. 1982;79(10):3129–3133.
   PubMed Web of Science ®Google Scholar
• Novak J, Cherry O, Osickova A, et al. Structure-function relationships underlying the capacity of Bordetella adenylate cyclase toxin to disarm host phagocytes. Toxins (Basel). 2017;9(10):300.
   PubMed Web of Science ®Google Scholar
• Guiso N. Bordetella adenylate cyclase-hemolysin toxins. Toxins (Basel). 2017;9(9):277.
   PubMed Web of Science ®Google Scholar
• Heiss LN, Moser SA, Unanue ER, et al. Interleukin-1 is linked to the respiratory epithelial cytopathology of pertussis. Infect Immun. 1993;61(8):3123–3128.
   PubMed Web of Science ®Google Scholar
• Flak TA, Goldman WE. Signalling and cellular specificity of airway nitric oxide production in pertussis. Cell Microbiol. 1999;1(1):51–60.
   PubMed Web of Science ®Google Scholar
• Kessie DK, Lodes N, Oberwinkler H, et al. Activity of tracheal cytotoxin of Bordetella pertussis in a human tracheobronchial 3D tissue model. Front Cell Infect Microbiol. 2021;10:614994.
   PubMed Web of Science ®Google Scholar
• Horiguchi Y, Nakai T, Kume K. Purification and characterization of Bordetella bronchiseptica dermonecrotic toxin. Microb Pathog. 1989;6(5):361–368.
   PubMed Web of Science ®Google Scholar
• Schmidt G, Goehring UM, Schirmer J, et al. Identification of the C-terminal part of Bordetella dermonecrotic toxin as a transglutaminase for Rho GTPases. J Biol Chem. 1999;274(45):31875–31881.
   PubMed Web of Science ®Google Scholar
• Teruya S, Hiramatzu Y, Nakamura K, et al. Bordetella dermonecrotic toxin is a neurotropic virulence factor that uses CaV3.1 as the cell surface receptor. mBio. 2020;11(2):e03146–19.
   PubMed Web of Science ®Google Scholar
• Kuwae A, Matsuzawa T, Ishikawa N, et al. BopC is a novel type III effector secreted by Bordetella bronchiseptica and has a critical role in type III-dependent necrotic cell death. J Biol Chem. 2006;281(10):6589–6600.
   PubMed Web of Science ®Google Scholar
• Kuwae A, Momose F, Nagamatsu K, et al. BteA secreted from the Bordetella bronchiseptica type III secretion system induces necrosis through an actin cytoskeleton signaling pathway and inhibits phagocytosis by macrophages. PLoS ONE. 2016;11(2):e0148387.
   PubMed Web of Science ®Google Scholar
• Bayram J, Malcova I, Sinkovec L, et al. Cytotoxicity of the effector protein BteA was attenuated in Bordetella pertussis by insertion of an alanine residue. PLoS Pathog. 2020;16(8):e1008512.
   PubMed Web of Science ®Google Scholar
• Abe A, Nishimura R, Kuwae A. Bordetella effector BopN is translocated into host cells via its N-terminal residues. Microbiol Immunol. 2017;61(6):206–214.
   PubMed Web of Science ®Google Scholar
• Nagamatsu K, Kuwae A, Konaka T, et al. Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med. 2009;206(13):3073–3088.
   PubMed Web of Science ®Google Scholar
• Jebb WHH, Tomlinson AHY. The catabolic activity of washed suspensions of Haemophilus pertussis. Microbiology. 1951;5(5):951–965.
   Web of Science ®Google Scholar
• Parkhill J, Sebaihia M, Preston A, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet. 2003;35(1):32–40.
   PubMed Web of Science ®Google Scholar
• Stainer DW, Scholte MJY. A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol. 1970;63(2):211–220.
   PubMedGoogle Scholar
• Izac M, Garnier D, Speck D, et al. A functional tricarboxylic acid cycle operates during growth of Bordetella pertussis on amino acid mixtures as sole carbon substrates. PLoS ONE. 2015;10(12):e0145251.
   PubMed Web of Science ®Google Scholar
• Brickman TJ, Suhadolc RJ, McKelvey PJ, et al. Essential role of Bordetella NadC in a quinolinate salvage pathway for NAD biosynthesis. Mol Microbiol. 2017;103(3):423–438.
   PubMed Web of Science ®Google Scholar
• Fröhlich BT, d'Alarcao M, Feldberg RS, et al. Formation and cell-medium partitioning of autoinhibitory free fatty acids and cyclodextrin’s effect in the cultivation of Bordetella pertussis. J Biotechnol. 1996;45(2):137–148.
   PubMed Web of Science ®Google Scholar
• Pollock MR. The growth of H. pertussis on media without blood. Br J Exp Pathol. 1947;28(4):295–307.
   PubMedGoogle Scholar
• Field LH, Parker CD. Effects of fatty acids on growth of Bordetella pertussis in defined medium. J Clin Microbiol. 1979;9(6):651–653.
   PubMed Web of Science ®Google Scholar
• MacArthur I, Belcher T, King JD, et al. The evolution of Bordetella pertussis has selected for mutations of acr that lead to sensitivity to hydrophobic molecules and fatty acids. Emerg Microb Infect. 2019;8(1):603–612.
   PubMed Web of Science ®Google Scholar
• Eby JC, Gray MC, Warfel JM, et al. Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection. Infect Immun. 2013;81(5):1390–1398.
   PubMed Web of Science ®Google Scholar
• Thalen M, Venema M, Dekker A, et al. Fed-batch cultivation of Bordetella pertussis: metabolism and pertussis toxin production. Biologicals. 2006;34(4):289–297.
   PubMed Web of Science ®Google Scholar
• Moon K, Bonocora RP, Kim DD, et al. The BvgAS regulon of Bordetella pertussis. mBio. 2017;8(5):e01526–17.
   PubMed Web of Science ®Google Scholar
• Wong TY, Hall JM, Nowak ES, et al. Analysis of the in vivo transcriptome of Bordetella pertussis during infection of mice. mSphere. 2019;4(2):e00154–19.
   PubMed Web of Science ®Google Scholar
• Belcher T, MacArthur I, King JD, et al. Fundamental differences in physiology of Bordetella pertussis dependent on the two-component system Bvg revealed by gene essentiality studies. Microb Genom. 2020;6(12):e000496.
   Web of Science ®Google Scholar
• Gonyar LA, Gelbach PE, McDuffie DG, et al. In vivo gene essentiality and metabolism in Bordetella pertussis. mSphere. 2019;4(3):e00694–18.
   PubMed Web of Science ®Google Scholar
• Vanderpool CK, Armstrong SK. The Bordetella bhu locus is required for heme iron utilization. J Bacteriol. 2001;183(14):4278–4287.
   PubMed Web of Science ®Google Scholar
• Regan JC, Tolstoouhov A. Relations of acid base equilibrium to the pathogenesis and treatment of whooping cough. NY State J. Med. 1936;36:1075–1087.
   Google Scholar
• Furman BL, Walker E, Sidey FM, et al. Slight hyperinsulinaemia but no hypoglycaemia in pertussis patients. J Med Microbiol. 1988;25(3):183–186.
   PubMed Web of Science ®Google Scholar
• Furman BL, Sidey FM, Wardlaw AC. Role of insulin in the hypoglycaemic effect of sublethal Bordetella pertussis infection in mice. Br J Exp Pathol. 1986;67(2):305–312.
   PubMedGoogle Scholar
• Katada T, Ui M. Slow interaction of islet-activating protein with pancreatic islets during primary culture to cause reversal of alpha-adrenergic inhibition of insulin secretion. J Biol Chem. 1980;255(20):9580–9588.
   PubMed Web of Science ®Google Scholar
• Toyota T, Kai Y, Kakizaki M, et al. Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies). Tohoku J Exp Med. 1980;130(2):105–116.
   PubMed Web of Science ®Google Scholar
• Elahi S, Brownlie R, Korzeniowski J, et al. Infection of newborn piglets with Bordetella pertussis: a new model for pertussis. Infect Immun. 2005;73(6):3636–3645.
   PubMed Web of Science ®Google Scholar
• Straub RH. Interaction of the endocrine system with inflammation: a function of energy and volume regulation. Arthritis Res Ther. 2014;16(1):203.
   PubMed Web of Science ®Google Scholar
• Macintyre AN, Gerriets VA, Nichols AG, et al. The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function. Cell Metab. 2014;20(1):61–72.
   PubMed Web of Science ®Google Scholar
• Palmer CS, Ostrowski M, Balderson B, et al. Glucose metabolism regulates T cell activation, differentiation, and functions. Front Immunol. 2015;6:1.
   PubMed Web of Science ®Google Scholar
• Gorringe AR, Woods G, Robinson A. Growth and siderophore production by Bordetella pertussis under iron-restricted conditions. FEMS Microbiol Lett. 1990;66(1–3):101–105.
   Web of Science ®Google Scholar
• Pradel E, Guiso N, Locht C. Identification of AlcR, an AraC-type regulator of alcaligin siderophore synthesis in Bordetella bronchiseptica and Bordetella pertussis. J Bacteriol. 1998;180(4):871–880.
   PubMed Web of Science ®Google Scholar
• Brickman TJ, Armstrong SK. Impact of alcaligin siderophore utilization on in vivo growth of Bordetella pertussis. Infect Immun. 2007;75(11):5305–5312.
   PubMed Web of Science ®Google Scholar
• Vanderpool CK, Armstrong SK. Integration of environmental signals controls expression of Bordetella heme utilization genes. J Bacteriol. 2004;186(4):938–948.
   PubMed Web of Science ®Google Scholar
• Brickman TJ, Vanderpool CK, Armstrong SK. Heme transport contributes to in vivo fitness of Bordetella pertussis during primary infection in mice. Infect Immun. 2006;74(3):1741–1744.
   PubMed Web of Science ®Google Scholar
• Brickman TJ, Hanawa T, Anderson MT, et al. Differential expression of Bordetella pertussis iron transport system genes during infection. Mol Microbiol. 2008;70(1):3–14.
   PubMed Web of Science ®Google Scholar
• Brickman TJ, Cummings CA, Liew SY, et al. Transcriptional profiling of the iron starvation response in Bordetella pertussis provides new insights into siderophore utilization and virulence gene expression. J Bacteriol. 2011;193(18):4798–4812.
   PubMed Web of Science ®Google Scholar
• Brickman TJ, Armstrong SK. Iron and pH-responsive FtrABCD ferrous iron utilization system of Bordetella species. Mol Microbiol. 2012;86(3):580–593.
   PubMed Web of Science ®Google Scholar
• Hayes JA, Lamberti Y, Surmann K, et al. Shotgun proteome analysis of Bordetella pertussis reveals a distinct influence of iron availability on the bacterial metabolism, virulence, and defense response. Proteomics. 2015;15(13):2258–2266.
   PubMed Web of Science ®Google Scholar
• Thalen M, van den Ijssel J, Jiskoot W, et al. Rational medium design for Bordetella pertussis: basic metabolism. J Biotechnol. 1999;75(2):147–159.
   PubMed Web of Science ®Google Scholar
• White C, Lee J, Kambe T, et al. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J Biol Chem. 2009;284(49):33949–33956.
   PubMed Web of Science ®Google Scholar
• Antoine R, Rivera-Millot A, Roy G, et al. Relationships between copper-related proteomes and lifestyles in β proteobacteria. Frontiers Microbiol. 2019;10:2217.
   PubMed Web of Science ®Google Scholar
• Rivera-Millot A, Slupek S, Chatagnon J, et al. Streamlined copper defenses make Bordetella pertussis reliant on custom-made operon. Commun Biol. 2021;4(1):46.
   PubMed Web of Science ®Google Scholar
• Taylor-Mulneix DL, Hamidou Soumana I, Linz B, et al. Evolution of Bordetellae from environmental microbes to human respiratory pathogens: amoebae as a missing link. Front Cell Infect Microbiol. 2017;7:510.
   PubMed Web of Science ®Google Scholar
• Greenberg D, Bamberger E, Ben-Shimol S, et al. Pertussis is under diagnosed in infants hospitalized with lower respiratory tract infection in the pediatric intensive care unit. Med Sci Monit. 2007;13(11):CR475–480.
   PubMed Web of Science ®Google Scholar
• Menozzi FD, Mutombo R, Renauld G, et al. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect Immun. 1994;62(3):769–778.
   PubMed Web of Science ®Google Scholar
• Relman D, Tuomanen E, Falkow S, et al. Recognition of a bacterial adhesin by an integrin: macrophage CR3 (αMβ2, CD11bCD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell. 1990;61(7):1375–1382.
   PubMed Web of Science ®Google Scholar
• Van Strijp JA, Russell DG, Tuomanen E, et al. Ligand specificity of purified complement receptor type three (CD11b/CD18, alpha m beta 2, Mac-1). Indirect effects of an arg-gly-asp (RGD) sequence. J Immunol. 1993;151(6):3324–3336.
   PubMed Web of Science ®Google Scholar
• Ishibashi Y, Claus S, Relman DA. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J Exp Med. 1994;180(4):1225–1233.
   PubMed Web of Science ®Google Scholar
• Prasad SM, Yi Y, Rodzinski E, et al. Identification of a carbohydrate recognition domain in filamentous hemagglutinin from Bordetella pertussis. Infect Immun. 1993;61(7):2780–2785.
   PubMed Web of Science ®Google Scholar
• Julio SM, Inatsuka CS, Mazar J, et al. Natural-host animal models indicate functional interchangeability between the filamentous haemagglutinins of Bordetella pertussis and Bordetella bronchiseptica and reveal a role for the mature C-terminal domain, but not the RGD motif, during infection. Mol Microbiol. 2009;71(6):1574–1590.
   PubMed Web of Science ®Google Scholar
• Hazenbos WL, van den Berg BM, Geuijen CW, et al. Binding of FimD on Bordetella pertussis to very late antigen-5 on monocytes activates complement receptor type 3 via protein tyrosine kinases. J Immunol. 1995;155(8):3972–3978.
   PubMed Web of Science ®Google Scholar
• Geuijen CA, Willems RJ, Bongaerts M, et al. Role of the Bordetella pertussis minor fimbrial subunit, fimd, in colonization of the mouse respiratory tract. Infect Immun. 1997;65(10):4222–4228.
   PubMed Web of Science ®Google Scholar
• Roberts M, Fairweather N, Leininger E, et al. Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein. Mol Microbiol. 1991;5(6):1393-1404.
   Web of Science ®Google Scholar
• Inatsuka CS, Xu Q, Vujkovic-Cvijin I, et al. Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun. 2010;78(7):2901–2909.
   PubMed Web of Science ®Google Scholar
• Hasan S, Kulkarni NN, Asbjarnarson A, et al. Bordetella pertussis adenylate cyclase toxin disrupts functional integrity of bronchial epithelial layers. Infect Immun. 2018;86(3):e00445–17.
   PubMed Web of Science ®Google Scholar
• Hoffman C, Eby J, Gray M, et al. Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro. Mol Microbiol. 2017;103(2):214–228.
   PubMed Web of Science ®Google Scholar
• Schaeffer LM, McCormack FX, Wu H, et al. Interactions of pulmonary collectins with Bordetella bronchiseptica and Bordetella pertussis lipopolysaccharide elucidate the structural basis of their antimicrobial activities. Infect Immun. 2004;72(12):7124–7130.
   PubMed Web of Science ®Google Scholar
• Schaeffer LM, McCormack FX, Wu H, et al. Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J Immunol. 2004;173(3):1959–1965.
   PubMed Web of Science ®Google Scholar
• Geurtsen J, Steeghs L, Hamstra HJ, et al. Expression of the lipopolysaccharide-modifying enzymes PagP and PagL modulates the endotoxic activity of Bordetella pertussis. Infect Immun. 2006;74(10):5574–5585.
   PubMed Web of Science ®Google Scholar
• Marr N, Tirsoaga A, Blanot D, et al. Glucosamine found as a substituent of both phosphate groups in Bordetella lipid A backbones: role of a BvgAS-activated arnt ortholog. J Bacteriol. 2008;190(12):4281–4290.
   PubMed Web of Science ®Google Scholar
• Geurtsen J, Dzieciatkowska M, Steeghs L, et al. Identification of a novel lipopolysaccharide core biosynthesis gene cluster in Bordetella pertussis, and influence of core structure and lipid A glucosamine substitution on endotoxic activity. Infect Immun. 2009;77(7):2602–2611.
   PubMed Web of Science ®Google Scholar
• Marr N, Hajjar AM, Shah NR, et al. Substitution of the Bordetella pertussis lipid A phosphate groups with glucosamine is required for robust NF-κb activation and release of proinflammatory cytokines in cells expressing human but not murine toll-like receptor 4-MD-2-CD14. Infect Immun. 2010;78(5):2060–2069.
   PubMed Web of Science ®Google Scholar
• Shah NR, Hancock REW, Fernandez RC. Bordetella pertussis lipid A glucosamine modification confers resistance to cationic antimicrobial peptides and increases resistance to outer membrane perturbation. Antimicrob Agents Chemother. 2014;58(8):4931–4934.
   PubMed Web of Science ®Google Scholar
• Parise G, Mishra M, Itoh Y, et al. Role of a putative polysaccharide locus in Bordetella biofilm development. J Bacteriol. 2007;189(3):750–760.
   PubMed Web of Science ®Google Scholar
• Conover MS, Mishra M, Deora R. Extracellular DNA is essential for maintaining Bordetella biofilm integrity on abiotic surfaces and in the upper respiratory tract of mice. PLoS ONE. 2011;6(2):e16861.
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.
   PubMed Web of Science ®Google Scholar
• Hovingh ES, van Gent M, Hamstra HJ, et al. Emerging Bordetella pertussis strains induce enhanced signaling of human pattern recognition receptors TLR2, NOD2 and secretion of IL-10 by dendritic cells. PLoS ONE. 2017;12(1):e0170027.
   PubMed Web of Science ®Google Scholar
• McGuirk P, Mahon BP, Griffin F, et al. Compartmentalization of T cell responses following respiratory infection with Bordetella pertussis: hyporesponsiveness of lung T cells is associated with modulated expression of the co-stimulatory molecule CD28. Eur J Immunol. 1998;28(1):153–163.
   PubMed Web of Science ®Google Scholar
• Rollins BJ. Chemokines. Blood. 1997;90(3):909–928.
   PubMed Web of Science ®Google Scholar
• Kirimanjeswara GS, Agosto LM, Kennett MJ, et al. Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest. 2005;115(12):3594–3601.
   PubMed Web of Science ®Google Scholar
• Andreasen C, Carbonetti NH. Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun. 2008;76(11):5139–5148.
   PubMed Web of Science ®Google Scholar
• Meade BD, Kind PD, Manclark CR. Altered mononuclear phagocyte function in mice treated with the lymphocytosis promoting factor of Bordetella pertussis. Dev Biol Stand. 1985;61:63–74.
   PubMedGoogle Scholar
• Spangrude GJ, Sacchi F, Hill HR, et al. Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J Immunol. 1985;135(6):4135–4143.
   PubMed Web of Science ®Google Scholar
• Friedman RL, Fiederlein RL, Glasser L, et al. Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions. Infect Immun. 1987;55(1):135–140.
   PubMed Web of Science ®Google Scholar
• Cundell DR, Kanthakumar K, Taylor GW, et al. Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro. Infect Immun. 1994;62(2):639–643.
   PubMed Web of Science ®Google Scholar
• Guermonprez P, Khelef N, Blouin E, et al. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the αmβ2 integrin (Cd11b/Cd18). J Exp Med. 2001;193(9):1035–1044.
   PubMed Web of Science ®Google Scholar
• Ahmad JN, Holubova J, Benada O, et al. Bordetella adenylate cyclase toxin inhibits monocyte-to-macrophage transition and dedifferentiates human alveolar macrophages into monocyte-like cells. mBio. 2019;10(5):e01743–19.
   PubMed Web of Science ®Google Scholar
• Sharma N, Akhade AS, Ismaeel S, et al. Serum-borne lipids amplify TLR-activated inflammatory responses. J Leukocyte Biol. 2021;109(4):821–831.
   PubMed Web of Science ®Google Scholar
• Hellwig SM, van Oirschot HF, Hazenbos WL, et al. Targeting the Fcgamma receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J Infect Dis. 2001;183(6):871–879.
   PubMed Web of Science ®Google Scholar
• Hazenbos WL, Berg BMVD, Furth RV. Very late antigen-5 and complement receptor type 3 cooperatively mediate the interaction between Bordetella pertussis and human monocytes. J Immunol. 1993;151(11):6274–6282.
   PubMed Web of Science ®Google Scholar
• Mobberley-Schuman PS, Weiss AA. Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun. 2005;73(11):7317–7323.
   PubMed Web of Science ®Google Scholar
• Cafiero JH, Lamberti YA, Surmann K, et al. A Bordetella pertussis MgtC homolog plays a role in the intracellular survival. PLoS ONE. 2018;13(8):e0203204.
   PubMed Web of Science ®Google Scholar
• Masure HR. The adenylate cyclase toxin contributes to the survival of Bordetella pertussis within human macrophages. Microb Pathog. 1993;14(4):253–260.
   PubMed Web of Science ®Google Scholar
• Cerny O, Kamanova J, Masin J, et al. Bordetella pertussis adenylate cyclase toxin blocks induction of bactericidal nitric oxide in macrophages through camp-dependent activation of the SHP-1 phosphatase. J Immunol. 2015;194(10):4901–4913.
   PubMed Web of Science ®Google Scholar
• Cerny O, Anderson KE, Stephens LR, et al. cAMP signaling of adenylate cyclase toxin blocks the oxidative burst of neutrophils through Epac-mediated inhibition of phospholipase C activity. J Immunol. 2017;198(3):1285–1296.
   PubMed Web of Science ®Google Scholar
• Pearson RD, Symes P, Conboy M, et al. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J Immunol. 1987;139(8):2749–2754.
   PubMed Web of Science ®Google Scholar
• Kamanova J, Kofronova O, Masin J, et al. Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling. J Immunol. 2008;181(8):5587–5597.
   PubMed Web of Science ®Google Scholar
• Fiser R, Masin J, Bumba L, et al. Calcium influx rescues adenylate cyclase-hemolysin from rapid cell membrane removal and enables phagocyte permeabilization by toxin pores. PLoS Pathog. 2012;8(4):e1002580.
   PubMed Web of Science ®Google Scholar
• Osicka R, Osickova A, Hasan S, et al. Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3. Elife. 2015;4:e10766.
   PubMed Web of Science ®Google Scholar
• Carbonetti NH, Artamonova GV, Van Rooijen N, et al. Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect Immun. 2007;75(4):1713–1720.
   PubMed Web of Science ®Google Scholar
• Schaeffer LM, Weiss AA. Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes. Infect Immun. 2001;69(12):7635–7641.
   PubMed Web of Science ®Google Scholar
• Cheung GY, Kelly SM, Jess TJ, et al. Functional and structural studies on different forms of the adenylate cyclase toxin of Bordetella pertussis. Microb Pathog. 2009;46(1):36–42.
   PubMed Web of Science ®Google Scholar
• Gueirard P, Druilhe A, Pretolani M, et al. Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun. 1998;66(4):1718–1725.
   PubMed Web of Science ®Google Scholar
• Ahmad JN, Cerny O, Linhartova I, et al. cAMP signalling of Bordetella adenylate cyclase toxin through the SHP-1 phosphatase activates the bimel-bax pro-apoptotic cascade in phagocytes. Cell Microbiol. 2016;18(3):384–398.
   PubMed Web of Science ®Google Scholar
• Basler M, Masin J, Osicka R, et al. Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes. Infect Immun. 2006;74(4):2207–2214.
   PubMed Web of Science ®Google Scholar
• Hewlett EL, Donato GM, Gray MC. Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP! Mol Microbiol. 2006;59(2):447–459.
   PubMed Web of Science ®Google Scholar
• Abramson T, Kedem H, Relman DA. Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin. Infect Immun. 2001;69(4):2650–2658.
   PubMed Web of Science ®Google Scholar
• Abramson T, Kedem H, Relman DA. Modulation of the NF-κB pathway by Bordetella pertussis filamentous hemagglutinin. PLoS ONE. 2008;3(11):e3825.
   PubMed Web of Science ®Google Scholar
• Barnes MG, Weiss AA. BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition. Infect Immun. 2001;69(5):3067–3072.
   PubMed Web of Science ®Google Scholar
• Berggard K, Johnsson E, Mooi FR, et al. Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect Immun. 1997;65(9):3638–3643.
   PubMed Web of Science ®Google Scholar
• Brookes C, Freire-Martin I, Cavelle B, et al. Bordetella pertussis isolates vary in their interactions with human complement components. Emerg Microbes Infect. 2018;7(1):1–11.
   PubMed Web of Science ®Google Scholar
• Hovingh ES, van den Broek B, Kuipers B, et al. Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surface. PLoS Pathog. 2017;13(7):e1006531.
   PubMed Web of Science ®Google Scholar
• Confer DL, Eaton JW. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science. 1982;217(4563):948–950.
   PubMed Web of Science ®Google Scholar
• Panina EM, Mattoo S, Griffith N, et al. A genome-wide screen identifies a Bordetella type III secretion effector and candidate effectors in other species. Mol Microbiol. 2005;58(1):267–279.
   PubMed Web of Science ®Google Scholar
• French CT, Panina EM, Yeh SH, et al. The Bordetella type III secretion system effector btea contains a conserved N-terminal motif that guides bacterial virulence factors to lipid rafts. Cell Microbiol. 2009;11(12):1735–1749.
   PubMed Web of Science ®Google Scholar
• Yuk MH, Harvill ET, Cotter PA, et al. Modulation of host immune responses, induction of apoptosis and inhibition of NF-kappaB activation by the Bordetella type III secretion system. Mol Microbiol. 2000;35(5):991–1004.
   PubMed Web of Science ®Google Scholar
• Ryan M, Murphy G, Ryan E, et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology. 1998;93(1):1–10.
   PubMed Web of Science ®Google Scholar
• Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol. 2013;6(4):787–796.
   PubMed Web of Science ®Google Scholar
• Ross PJ, Sutton CE, Higgins S, et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog. 2013;9(4):e1003264.
   PubMed Web of Science ®Google Scholar
• Dubois V, Chatagnon J, Thiriard A, et al. Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage. Npj Vaccines. 2021;6(1):1–10.
   PubMed Web of Science ®Google Scholar
• Borkner L, Curham LM, Wilk MM, et al. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially siglec-F(+) neutrophils. Mucosal Immunol. 2021;14(5):1183-1202.
   Web of Science ®Google Scholar
• Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity. 2004;21(4):467–476.
   PubMed Web of Science ®Google Scholar
• Wu V, Smith AA, You H, et al. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol. 2016;9(3):777–786.
   PubMed Web of Science ®Google Scholar
• Fennelly NK, Sisti F, Higgins SC, et al. Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses. Infect Immun. 2008;76(3):1257–1266.
   PubMed Web of Science ®Google Scholar
• Dieterich C, Relman DA. Modulation of the host interferon response and ISGylation pathway by B. pertussis filamentous hemagglutinin. PLoS ONE. 2011;6(11):e27535.
   PubMed Web of Science ®Google Scholar
• Nguyen TM, Ravindra D, Kwong B, et al. Differential expression of alpha 4 integrins on effector memory T helper cells during Bordetella infections. delayed responses in Bordetella pertussis. PLoS ONE. 2012;7(12):e52903.
   PubMed Web of Science ®Google Scholar
• Andreasen C, Powell DA, Carbonetti NH. Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS ONE. 2009;4(9):e7079.
   PubMed Web of Science ®Google Scholar
• Connelly CE, Sun Y, Carbonetti NH. Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection. Infect Immun. 2012;80(12):4317–4332.
   PubMed Web of Science ®Google Scholar
• Lindén A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur Resp J. 2005;25(1):159–172.
   PubMed Web of Science ®Google Scholar
• Aujla SJ, Dubin PJ, Kolls JK. Interleukin-17 in pulmonary host defense. Exp Lung Res. 2007;33(10):507–518.
   PubMed Web of Science ®Google Scholar
• Arumugham VB, Ulivieri C, Onnis A, et al. Compartmentalized cyclic AMP production by the Bordetella pertussis and Bacillus anthracis adenylate cyclase toxins differentially affects the immune synapse in T lymphocytes. Front Immunol. 2018;9:919.
   PubMed Web of Science ®Google Scholar
• Paccani SR, Finetti F, Davi M, et al. The Bordetella pertussis adenylate cyclase toxin binds to T cells via LFA-1 and induces its disengagement from the immune synapse. J Exp Med. 2011;208(6):1317–1330.
   PubMed Web of Science ®Google Scholar
• Rossi Paccani S, Benagiano M, Capitani N, et al. The adenylate cyclase toxins of Bacillus anthracis and Bordetella pertussis promote Th2 cell development by shaping T cell antigen receptor signaling. PLoS Pathog. 2009;5(3):e1000325.
   PubMed Web of Science ®Google Scholar
• Bagley KC, Abdelwahab SF, Tuskan RG, et al. Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J Leukocyte Biol. 2002;72(5):962–969.
   PubMed Web of Science ®Google Scholar
• Fedele G, Spensieri F, Palazzo R, et al. Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways. PLoS ONE. 2010;5(1):e8734.
   PubMed Web of Science ®Google Scholar
• Ross PJ, Lavelle EC, Mills KHG, et al. Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun. 2004;72(3):1568–1579.
   PubMed Web of Science ®Google Scholar
• Spensieri F, Fedele G, Fazio C, et al. Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect Immun. 2006;74(5):2831–2838.
   PubMed Web of Science ®Google Scholar
• Henderson MW, Inatsuka CS, Sheets AJ, et al. Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation. Infect Immun. 2012;80(6):2061–2075.
   PubMed Web of Science ®Google Scholar
• Adkins I, Kamanova J, Kocourkova A, et al. Bordetella adenylate cyclase toxin differentially modulates toll-like receptor-stimulated activation, migration and T cell stimulatory capacity of dendritic cells. PLoS ONE. 2014;9(8):e104064.
   PubMed Web of Science ®Google Scholar
• Dunne A, Ross PJ, Pospisilova E, et al. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J Immunol. 2010;185(3):1711–1719.
   PubMed Web of Science ®Google Scholar
• Ronchi F, Basso C, Preite S, et al. Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells. Nat Commun. 2016;7(1):11541.
   PubMedGoogle Scholar
• Bassinet L, Fitting C, Housset B, et al. Bordetella pertussis adenylate cyclase-hemolysin induces interleukin-6 secretion by human tracheal epithelial cells. Infect Immun. 2004;72(9):5530–5533.
   PubMed Web of Science ®Google Scholar
• den Hartog G, Schijf MA, Berbers GAM, et al. Bordetella pertussis induces interferon gamma production by natural killer cells, resulting in chemoattraction by respiratory epithelial cells. J Infect Dis. 2020; (jiaa140). 10.1093/infdis/jiaa140.
   PubMed Web of Science ®Google Scholar
• Kampf C, Relova AJ, Sandler S, et al. Effects of TNF-alpha, IFN-gamma and IL-beta on normal human bronchial epithelial cells. Eur Resp J. 1999;14(1):84–91.
   PubMed Web of Science ®Google Scholar
• Diehl S, Rincón M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol. 2002;39(9):531–536.
   PubMed Web of Science ®Google Scholar
• Bianchi M, Sivarajan R, Walles T, et al. Susceptibility of primary human airway epithelial cells to Bordetella pertussis adenylate cyclase toxin in two- and three-dimensional culture conditions. Innate Immun. 2021;27(1):89–98.
   PubMed Web of Science ®Google Scholar
• McGuirk P, Mills KHG. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol. 2000;30(2):415–422.
   PubMed Web of Science ®Google Scholar
• Villarino Romero R, Hasan S, Fae K, et al. Bordetella pertussis filamentous hemagglutinin itself does not trigger anti-inflammatory interleukin-10 production by human dendritic cells. Int J Med Microbiol. 2016;306(1):38–47.
   PubMed Web of Science ®Google Scholar
• Dirix V, Mielcarek N, Debrie AS, et al. Human dendritic cell maturation and cytokine secretion upon stimulation with Bordetella pertussis filamentous haemagglutinin. Microbes Infect. 2014;16(7):562–570.
   PubMed Web of Science ®Google Scholar
• Fedele G, Celestino I, Spensieri F, et al. Lipooligosaccharide from Bordetella pertussis induces mature human monocyte-derived dendritic cells and drives a Th2 biased response. Microb Infect. 2007;9(7):855–863.
   PubMed Web of Science ®Google Scholar
• Fedele G, Nasso M, Spensieri F, et al. Lipopolysaccharides from Bordetella pertussis and Bordetella parapertussis differently modulate human dendritic cell functions resulting in divergent prevalence of Th17-polarized responses. J Immunol. 2008;181(1):208–216.
   PubMed Web of Science ®Google Scholar
• Hovingh ES, Mariman R, Solans L, et al. Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor. Emerg Microbes Infect. 2018;7(1):39.
   PubMed Web of Science ®Google Scholar
• Rivera-Chavez F, Mekalanos JJ. Cholera toxin promotes pathogen acquisition of host-derived nutrients. Nature. 2019;572(7768):244–248.
   PubMed Web of Science ®Google Scholar
• Robertson AM, Wright DP. Bacterial glycosulphatases and sulphomucin degradation. Can J Gastroenterol. 1997;11(4):361–366.
   PubMedGoogle Scholar
• Nieuw Amerongen AV, Bolscher JG, Bloemena E, et al. Sulfomucins in the human body. Biol Chem. 1998;379(1):1–18.
   PubMed Web of Science ®Google Scholar
• Schwartz KL, Kwong JC, Deeks SL, et al. Effectiveness of pertussis vaccination and duration of immunity. CMAJ. 2016;188(16):E399–E406. E399-E406.
   PubMed Web of Science ®Google Scholar
• Zhang L, Prietsch SO, Axelsson I, et al. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev. 2014;9:CD001478.
   PubMed Web of Science ®Google Scholar
• Olin P, Rasmussen F, Gustafsson L, et al. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. ad hoc group for the study of pertussis vaccines. Lancet. 1997;350(9091):1569–1577.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Nagai M. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther. 2004;2(3):447–454.
   PubMedGoogle Scholar
• Pierce C, Klein N, Peters M. Is leukocytosis a predictor of mortality in severe pertussis infection? Intensive Care Med. 2000;26(10):1512–1514.
   PubMed Web of Science ®Google Scholar
• Petersen RF, Dalby T, Dragsted MD, et al. Temporal trends in Bordetella pertussis populations, Denmark, 1949–2010. Emerg Infect Dis. 2012;18(5):767–774.
   PubMed Web of Science ®Google Scholar
• Schmidtke AJ, Boney KO, Martin SW, et al. Population diversity among Bordetella pertussis isolates, United States, 1935–2009. Emerg Infect Dis. 2012;18(8):1248–1255.
   PubMed Web of Science ®Google Scholar
• Mooi FR, van Loo IH, van Gent M, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis. 2009;15(8):1206–1213.
   PubMed Web of Science ®Google Scholar
• Advani A, Gustafsson L, Carlsson AM, et al. Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype. APMIS. 2007;115(6):736–742.
   PubMed Web of Science ®Google Scholar
• Octavia S, Sintchenko V, Gilbert GL, et al. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008–2010. J Infect Dis. 2012;205(8):1220–1224.
   PubMed Web of Science ®Google Scholar
• Bart MJ, Harris SR, Advani A, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. mBio. 2014;5(2):e01074.
   PubMed Web of Science ®Google Scholar
• Clarke M, McIntyre PB, Blyth CC, et al. The relationship between Bordetella pertussis genotype and clinical severity in Australian children with pertussis. J Infect. 2016;72(2):171–178.
   PubMed Web of Science ®Google Scholar
• Barkoff A-M, Mertsola J, Pierard D, et al. Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Eurosurveillance. 2019;24(7):1700832.
   Web of Science ®Google Scholar
• Bouchez V, Brun D, Cantinelli T, et al. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine. 2009;27(43):6034–6041.
   PubMed Web of Science ®Google Scholar
• Williams MM, Sen K, Weigand MR, et al. Bordetella pertussis strain lacking pertactin and pertussis toxin. Emerg Infect Dis. 2016;22(2):319–322.
   PubMed Web of Science ®Google Scholar
• Mooi FR, Van Der Maas NA, De Melker HE. Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin. Epidemiol Infect. 2014;142(4):685–694.
   PubMed Web of Science ®Google Scholar
• Luu LDW, Octavia S, Zhong L, et al. Comparison of the whole cell proteome and secretome of epidemic Bordetella pertussis strains from the 2008–2012 Australian epidemic under sulfate-modulating conditions. Front Microbiol. 2018;9:2851.
   PubMed Web of Science ®Google Scholar
• Etskovitz H, Anastasio N, Green E, et al. Role of evolutionary selection acting on vaccine antigens in the re-emergence of Bordetella pertussis. Diseases. 2019;7(2):35.
   PubMedGoogle Scholar
• Hellwig SM, Rodriguez ME, Berbers GA, et al. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J Infect Dis. 2003;188(5):738–742.
   PubMed Web of Science ®Google Scholar
• Lesne E, Cavell BE, Freire-Martin I, et al. Acellular pertussis vaccines induce anti-pertactin bactericidal antibodies which drives the emergence of pertactin-negative strains. Front Microbiol. 2020;11:2108.
   PubMed Web of Science ®Google Scholar
• Moot FR, van Oirschot H, Heuvelman K, et al. Polymorphism in the Bordetella pertussis virulence factors p.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun. 1998;66(2):670–675.
   PubMed Web of Science ®Google Scholar
• Mastrantonio P, Spigaglia P, Oirschot HV, et al. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiol-SGM. 1999;145(8):2069–2075.
   PubMedGoogle Scholar
• Safarchi A, Octavia S, Luu LD, et al. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model. Vaccine. 2015;33(46):6277–6281.
   PubMed Web of Science ®Google Scholar
• Zeddeman A, van Gent M, Heuvelman CJ, et al. Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Eurosurveillance. 2014;19(33):20881.
   Web of Science ®Google Scholar
• Lam C, Octvaia S, Ricafort L, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis. 2014;20(4):626–633.
   PubMed Web of Science ®Google Scholar
• Martin SW, Pawloski L, Williams M, et al. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis. 2015;60(2):223–227.
   PubMed Web of Science ®Google Scholar
• Zeddeman A, van Schuppen E, Kok KE, et al. Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site. PLoS ONE. 2020;15(8):e0237394.
   PubMedGoogle Scholar
• Storsaeter J, Hallander HO, Gutsafsson L, et al. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 1998;16(20):1907–1916.
   PubMed Web of Science ®Google Scholar
• Van Buynder PG, Owen D, Vurdien JE, et al. Bordetella pertussis surveillance in England and Wales: 1995–7. Epidemiol Infect. 1999;123(3):403–411.
   PubMed Web of Science ®Google Scholar
• Weigand MR, Peng Y, Loparev V, et al. The history of Bordetella pertussis genome evolution includes structural rearrangement. J Bacteriol. 2017;199(8):e00806–16.
   PubMed Web of Science ®Google Scholar
• King AJ, Berbers G, van Oirschot HF, et al. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiol-SGM. 2001;147(11):2885–2895.
   PubMedGoogle Scholar
• Watanabe M, Nagai M. Effect of acellular pertussis vaccine against various strains of Bordetella pertussis in a murine model of respiratory infection. J Health Science. 2002;48(6):560–564
   Google Scholar
• Gzyl A, Augustynowicz E, Gniadek G, et al. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine. 2004;22(17):2122–2128.
   PubMed Web of Science ®Google Scholar
• Jayasundara D, Lee E, Octavia S, et al. Emergence of pertactin-deficient pertussis strains in Australia can be explained by models of vaccine escape. Epidemics. 2020;31:100388.
   PubMed Web of Science ®Google Scholar
• Preston A, Parkhill J, Maskell DJ. The Bordetellae: lessons from genomics. Nat Rev Microbiol. 2004;2(5):379–390.
   PubMed Web of Science ®Google Scholar
• Bouchez V, Caro V, Levillain E, et al. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. PLoS ONE. 2008;3(6):e2437.
   PubMed Web of Science ®Google Scholar
• Otsuka N, Han HJ, Toyoizumi-Ajisaka H, et al. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS ONE. 2012;7(2):e31985.
   PubMed Web of Science ®Google Scholar
• Sealey KL, Harris SR, Fry NK, et al. Genomic analysis of isolates from the united kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving. J Infect Dis. 2015;212(2):294–301.
   PubMed Web of Science ®Google Scholar
• Weigand MR, Peng Y, Batra D, et al. Conserved patterns of symmetric inversion in the genome evolution of Bordetella respiratory pathogens. mSystems. 2019;4(6):e00702–19.
   PubMed Web of Science ®Google Scholar
• Dienstbier A, Amman F, Petrackova D, et al. Comparative omics analysis of historic and recent isolates of Bordetella pertussis and effects of genome rearrangements on evolution. Emerg Infect Dis. 2021;27(1):57–68.
   PubMed Web of Science ®Google Scholar
• Liow LH, Van Valen L, Stenseth NC. Red Queen: from populations to taxa and communities. Trends Ecol Evol. 2011;26(7):349–358.
   PubMed Web of Science ®Google Scholar
• Van Valen L. The Red Queen. Am Nat. 1977;111(980):809–810.
   Google Scholar
• Decaestecker E, Gaba S, Raeymaekers JA, et al. Host–parasite ‘red queen’ dynamics archived in pond sediment. Nature. 2007;450(7171):870–873.
   PubMed Web of Science ®Google Scholar
• Marr N, Novikov A, Hajjar AM, et al. Variability in the lipooligosaccharide structure and endotoxicity among Bordetella pertussis strains. J Infect Dis. 2010;202(12):1897–1906.
   PubMed Web of Science ®Google Scholar
• Nasso M, Fedele G, Spensieri F, et al. Genetically detoxified pertussis toxin induces Th1/Th17 immune response through MAPKs and IL-10-dependent mechanisms. J Immunol. 2009;183(3):1892–1899.
   PubMed Web of Science ®Google Scholar
• Flak TA, Heiss LN, Engle JT, et al. Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. Infect Immun. 2000;68(3):1235–1242.
   PubMed Web of Science ®Google Scholar
• Magalhaes JG, Philpott DJ, Nahori MA., et al. Murine NOD1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep. 2005;6(12):1201–1207.
   PubMed Web of Science ®Google Scholar
• Paik D, Monahan A, Caffrey DR, et al. SLC46 family transporters facilitate cytosolic innate immune recognition of monomeric peptidoglycans. J Immunol. 2017;199(1):263–270.
   PubMed Web of Science ®Google Scholar
• Fedele G, Schiavoni I, Adkins I, et al. Invasion of dendritic dells, macrophages and neutrophils by the Bordetella adenylate cyclase toxin: a subversive move to fool host immunity. Toxins (Basel). 2017;9(10):293.
   PubMed Web of Science ®Google Scholar
• Svedova M, Masin J, Fiser R, et al. Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells. Immunol Cell Biol. 2016;94(4):322–333.
   PubMed Web of Science ®Google Scholar